| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |